Bone metastasis: detection by 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/ computed tomography (CT) in lung cancer patients

This poster was originally presented at the ESTI 2012 meeting, June 22-24, in London/UK. www.myESTI.org

Congress:

ESTI 2012

Poster Number:

E-0001

Type:

Scientific Exhibit

Keywords:

Bones, Lung, Oncology, CT, PET-CT, Molecular imaging, Neoplasia

Authors:

A. Panunzio, A. Panunzio, R. Polverosi, F. Pomerri, P. C. Muzzio, L. Evangelista; Padua/IT

DOI:

10.1594/esti2012/E-0001

DOI-Link:

https://dx.doi.org/10.1594/esti2012/E-0001

Materials and Methods

We retrospectively selected 57 patients (45 male and 12 female; median age: 70 years) with lung cancer (24 adenocarcinoma, 6 SCLC, 12 NSCLC and 15 not disposable) who underwent FDG PET/CT for initial staging (n=16, 28%), restaging (n=32, 56%) and follow-up (n=9, 16%) (Figure 1). All images were re-evaluated by a nuclear medicine physician and a radiologist. All site of metastases were registered and confirmed by follow-up imaging or by histological staining. The distribution of bone metastases was determined and described.